The most novel developments in molecular medicine are implemented in all treatment plans for all haematological diseases. These include:

• Benign haematological diseases, such as anaemia, thrombocytopenia, and haemostatic disorders.
• Haematological malignancies, such as leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms.

Our Bone Marrow Transplant and New Cell

Therapies Unit will be the first of its kind in Cyprus. It will cover cellular therapies for haematological and non-haematological diseases such as:

• Autologous and allogeneic haematopoietic cell transplants for haematological malignancies
• Autologous haematopoietic cell transplants for non-haematological malignancies and autoimmune diseases (e.g., for solid tumors, multiple sclerosis)
• New cell therapies for the treatment of haematological malignancies (CAR-T cells) and inherited diseases (e.g., gene therapy for beta-thalassemia)